Laboratory Corporation of America Holdings (LabCorp)
1447 York Court
Burlington
North Carolina
27215
United States
Tel: 336-584-5171 or 800-331-2843
Website: http://www.labcorp.com/
411 articles about Laboratory Corporation of America Holdings (LabCorp)
-
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
4/24/2023
Enzo Biochem, Inc. announced that its special meeting of shareholders to consider and vote on a proposal to approve the sale of substantially all the assets and assignment of certain liabilities of its clinical laboratory business to Labcorp and adopt the Asset Purchase Agreement, dated as of March 16, 2023, by and among the Company, Enzo Clinical Labs, Inc., a New York corporation and Labcorp will be held on May 22, 2023 at 9:00 a.m. Eastern Time.
-
It does not require healthcare workers and first responders to conduct the test using personal protective equipment. Therefore, it should prevent the risk of transmitting the virus.
-
There has been a spate of recent news regarding the expansion of facilities and the expected job growth for the biopharma and life sciences industry. Here’s a look at some of those stories.
-
As the timeline shortens for Albert Bourla to take over the reins of Pfizer from Chief Executive Officer Ian Read, the company has released details of the new senior management team that will continue to lead the company forward.
-
MC10 Enters Strategic Collaboration With LabCorp, Including Equity Investment, to Advance Clinical Trial Innovation and Healthcare Diagnostics
11/2/2017
As part of the collaboration, LabCorp has also made an equity investment into MC10.
-
LabCorp and Capital Health Enter Comprehensive Laboratory Partnership
11/1/2017
The collaboration will provide physicians and patients in the region with enhanced and streamlined access to a full range of laboratory testing solutions.
-
LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance
10/25/2017
LabCorp today announced results for the third quarter ended September 30, 2017, and increased its 2017 guidance.
-
Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
10/2/2017
-
LabCorp Objects To Proposed PAMA 2018 Medicare Payment Rates For Clinical Laboratory Tests; Calls For Delay In Implementation To Avoid Significant Harm To Medicare Beneficiaries
9/25/2017
-
LabCorp Presents Nine Studies, Including Novel Research On Improving Genetic Counseling Quality, At The National Society Of Genetic Counselors Annual Conference
9/15/2017
-
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Interest
9/12/2017
-
LabCorp Completes Acquisition Of Chiltern International Ltd.
9/1/2017
-
Interpace Diagnostics Announces Renewal And Extension Of LabCorp National Agreement
8/28/2017
-
LabCorp’s Acquisition Of Chiltern International Ltd. Clears Antitrust Review
8/25/2017
-
Omniseq And LabCorp Sign Exclusive Distribution Agreement And Series B Funding Commitment
8/21/2017
-
LabCorp Prices $600,000,000 In 3.250% Senior Notes Due 2024 And $600,000,000 In 3.600% Senior Notes Due 2027
8/16/2017
-
LabCorp Announces Proposed Sale Of Senior Notes
8/15/2017
-
LabCorp Announces Proposed Sale Of Senior Notes
8/15/2017
-
LabCorp Scoops Up Giant CRO for Approximately $1.2 Billion Cash
8/1/2017
-
LabCorp Announces Record Results In The Second Quarter Of 2017 And Increases 2017 Guidance
7/26/2017